The protective effect of SARS-CoV-2 antibodies in Scottish healthcare workers
- PMID: 34104643
- PMCID: PMC8164012
- DOI: 10.1183/23120541.00080-2021
The protective effect of SARS-CoV-2 antibodies in Scottish healthcare workers
Abstract
Background: Healthcare workers (HCWs) are believed to be at increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. It is not known to what extent the natural production of antibodies to SARS-CoV-2 is protective against re-infection.
Methods: A prospective observational study of HCWs in Scotland (UK) from May to September 2020 was performed. The Siemens SARS-CoV-2 total antibody assay was used to establish seroprevalence in this cohort. Controls, matched for age and sex to the general local population, were studied for comparison. New infections (up to 2 December 2020) post antibody testing were recorded to determine whether the presence of SARS-CoV-2 antibodies protects against re-infection.
Results: A total of 2063 health and social care workers were recruited for this study. At enrolment, 300 HCWs had a positive antibody test (14.5%). 11 out of 231 control sera tested positive (4.8%). HCWs therefore had an increased likelihood of a positive test (OR 3.4, 95% CI 1.85-6.16; p<0.0001). Dentists were most likely to test positive. 97.3% of patients who had previously tested positive for SARS-CoV-2 by reverse transcriptase (RT)-PCR had positive antibodies. 18.7% had an asymptomatic infection. There were 38 new infections with SARS-CoV-2 in HCWs who were previously antibody negative, and one symptomatic RT-PCR-positive re-infection. The presence of antibodies was therefore associated with an 85% reduced risk of re-infection with SARS-CoV-2 (hazard ratio 0.15, 95% CI 0.06-0.35; p=0.026).
Conclusion: HCWs were three times more likely to test positive for SARS-CoV-2 than the general population. Almost all infected individuals developed an antibody response, which was 85% effective in protecting against re-infection with SARS-CoV-2.
Copyright ©The authors 2021.
Conflict of interest statement
Conflict of interest: H. Abo-Leyah has nothing to disclose. Conflict of interest: S. Gallant has nothing to disclose. Conflict of interest: D. Cassidy has nothing to disclose. Conflict of interest: Y.H. Giam has nothing to disclose. Conflict of interest: J. Killick has nothing to disclose. Conflict of interest: B. Marshall has nothing to disclose. Conflict of interest: G. Hay has nothing to disclose. Conflict of interest: C. Snowdon has nothing to disclose. Conflict of interest: E.J. Hothersall has nothing to disclose. Conflict of interest: T. Pembridge has nothing to disclose. Conflict of interest: R. Strachan has nothing to disclose. Conflict of interest: N. Gallant has nothing to disclose. Conflict of interest: B.J. Parcell has nothing to disclose. Conflict of interest: J. George has nothing to disclose. Conflict of interest: E. Furrie has nothing to disclose. Conflict of interest: J.D. Chalmers reports grants and personal fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Insmed; personal fees from Chiesi, Novartis and Zambon; and grants from Gilead Sciences, all outside the submitted work.
Figures



Similar articles
-
Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.J Infect Public Health. 2021 Oct;14(10):1466-1473. doi: 10.1016/j.jiph.2021.06.001. Epub 2021 Jun 10. J Infect Public Health. 2021. PMID: 34175238 Free PMC article.
-
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.Indian J Med Res. 2021 Jan & Feb;153(1 & 2):207-213. doi: 10.4103/ijmr.IJMR_3911_20. Indian J Med Res. 2021. PMID: 33642348 Free PMC article.
-
Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.Epidemiol Infect. 2021 Apr 27;149:e157. doi: 10.1017/S0950268821000984. Epidemiol Infect. 2021. PMID: 33902786 Free PMC article.
-
Low prevalence of SARS-CoV-2 specific antibodies among endoscopists and their assistants in a university hospital in Tochigi prefecture-A single-center study.DEN Open. 2021 Dec 3;2(1):e79. doi: 10.1002/deo2.79. eCollection 2022 Apr. DEN Open. 2021. PMID: 35310745 Free PMC article.
-
An Integrated Strategy for the Prevention of SARS-CoV-2 Infection in Healthcare Workers: A Prospective Observational Study.Int J Environ Res Public Health. 2020 Aug 10;17(16):5785. doi: 10.3390/ijerph17165785. Int J Environ Res Public Health. 2020. PMID: 32785110 Free PMC article.
Cited by
-
SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan.Int J Environ Res Public Health. 2021 Apr 5;18(7):3786. doi: 10.3390/ijerph18073786. Int J Environ Res Public Health. 2021. PMID: 33916399 Free PMC article.
-
Seroprevalence in health care workers during the later phase of the second wave: Results of three hospitals in Serbia, prior to vaccine administration.J Infect Public Health. 2022 Jul;15(7):739-745. doi: 10.1016/j.jiph.2022.05.009. Epub 2022 May 25. J Infect Public Health. 2022. PMID: 35691217 Free PMC article.
-
Protective effectiveness of previous infection against subsequent SARS-Cov-2 infection: systematic review and meta-analysis.Front Public Health. 2024 Jun 20;12:1353415. doi: 10.3389/fpubh.2024.1353415. eCollection 2024. Front Public Health. 2024. PMID: 38966699 Free PMC article.
-
COVID-19 incidence and vaccination rates among Canadian dental hygienists.Can J Dent Hyg. 2022 Oct 1;56(3):123-130. eCollection 2022 Oct. Can J Dent Hyg. 2022. PMID: 36451991 Free PMC article.
-
The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti-Cancer Treatment.Oncologist. 2023 Mar 17;28(3):e145-e155. doi: 10.1093/oncolo/oyac257. Oncologist. 2023. PMID: 36719033 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous